A股異動丨佩蒂股份漲停 2019年我國寵物市場規模將達1200億元
格隆匯12月13日丨佩蒂股份(300673.SZ)漲停,報26.47元,總市值39億元。2018年我國寵物市場規模約1000億,預計2019年將達到1200億元。若平均消費對標美國,户均寵物數量對標日本,那麼我國寵物市場潛在規模約為7500億元。中國寵物行業仍處於發展初期,格局散、增速快、空間大,疊加電商崛起、政策利好、資本助力等多個機會,本土公司大有可為。佩蒂股份主要從事寵物食品的研發、生產和銷售,主要產品為畜皮咬膠、植物咬膠、營養肉質零食、鳥食及可食用小動物玩具、烘焙餅乾等系列產品,其中寵物咬膠產品銷售額在全國寵物咬膠生產企業中遙遙領先。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.